Abstract
Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Drug Delivery Letters
Title: SiO2 NPs: Promising Candidates for Drug and Gene Delivery
Volume: 1 Issue: 1
Author(s): Giuseppe Bardi
Affiliation:
Keywords: Nanoparticles, silica, drug delivery, biocompatibility, toxicity, nanomedicine
Abstract: Nanoparticles of several organic and inorganic materials are nowadays under investigation for many diverse technologies. Amorphous silicon dioxide, also known as silica, is a versatile material for nanostructure preparation. Silica nanoparticles with different structure or surface chemistry have been prepared for biomedical applications. Size, shape and functionalization rule nanoparticle interaction with cells and tissues finally regulating the potential toxic effects. “Ad hoc” surface chemical moieties and specific physical features of their structure increase silica nanoparticle biocompatibility suggesting their possible future employment for gene or drug delivery.
Export Options
About this article
Cite this article as:
Bardi Giuseppe, SiO2 NPs: Promising Candidates for Drug and Gene Delivery, Drug Delivery Letters 2011; 1 (1) . https://dx.doi.org/10.2174/2210304x11101010009
DOI https://dx.doi.org/10.2174/2210304x11101010009 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Comparison of Various Types of Ligand Decorated Nanoliposomes for their Ability to Inhibit Amyloid Aggregation and to Reverse Amyloid Cytotoxicity
Current Topics in Medicinal Chemistry Pharmacogenomics of Breast Cancer Targeted Therapy: Focus on Recent Patents
Recent Patents on DNA & Gene Sequences A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Therapies of Cancer
Current Cancer Therapy Reviews Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol
CNS & Neurological Disorders - Drug Targets Oxidative Stress in Tumor Angiogenesis - Therapeutic Targets
Current Pharmaceutical Design Namitecan: a Hydrophilic Camptothecin with a Promising Preclinical Profile
Current Medicinal Chemistry Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption
Recent Patents on Anti-Cancer Drug Discovery NMR Structural Studies of Human Cellular Prion Proteins
Current Topics in Medicinal Chemistry Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Current Pharmaceutical Design Immunotherapy Resistance Mechanisms in Renal Cell Cancer
Current Signal Transduction Therapy Observations on the Use of the Avian Chorioallantoic Membrane (CAM) Model in Investigations into Angiogenesis
Current Drug Targets - Cardiovascular & Hematological Disorders Sphingolipids as Emerging Drug Targets: Therapeutic Applications of Ceramide Analogs
Drug Design Reviews - Online (Discontinued) Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Current Signal Transduction Therapy Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity
Current Cancer Drug Targets Editorial [Hot Topic:Treatment of Neuroblastoma: From Cellular to Molecular Therapy (Executive Editor: Gian Paolo Tonini)]
Current Pharmaceutical Design Novel Systemic Markers for Patients with Alzheimer Disease? – A Pilot Study
Current Alzheimer Research Network Propagation Reveals Novel Features Predicting Drug Response of Cancer Cell Lines
Current Bioinformatics New Medical Strategies for Midgut Carcinoids
Anti-Cancer Agents in Medicinal Chemistry Recent Developments in CE-MS Based Metabolomics
Current Analytical Chemistry